Search Count: 47
![]() |
Organism: Homo sapiens, Influenza a virus
Method: ELECTRON MICROSCOPY Resolution:3.15 Å Release Date: 2026-06-10 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
![]() |
Organism: Influenza a virus, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2026-05-27 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
![]() |
Organism: Homo sapiens, Influenza a virus
Method: ELECTRON MICROSCOPY Release Date: 2026-05-27 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
![]() |
Organism: Influenza a virus, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2026-05-27 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
![]() |
Organism: Homo sapiens, Influenza a virus
Method: ELECTRON MICROSCOPY Resolution:2.93 Å Release Date: 2026-05-27 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
![]() |
Organism: Influenza a virus, Homo sapiens
Method: ELECTRON MICROSCOPY Resolution:3.48 Å Release Date: 2026-05-27 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
![]() |
Cryo-Em Local Refinement Of Antibody 19-77 In Complex With Prefusion Sars-Cov-2 Spike Glycoprotein Rbd
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2025-07-02 Classification: VIRAL PROTEIN/IMMUNE SYSTEM |
![]() |
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2025-07-02 Classification: VIRAL PROTEIN/IMMUNE SYSTEM |
![]() |
Cryo-Em Refinement Of Antibody 19-77 R71V In Complex With Sars-Cov-2 Hk.3 Rbd
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2025-07-02 Classification: VIRAL PROTEIN/IMMUNE SYSTEM |
![]() |
Cryo-Em Refinement Of Antibody 19-77 R71V In Complex With Sars-Cov-2 Jd.1.1 Rbd
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-07-02 Classification: VIRAL PROTEIN/IMMUNE SYSTEM |
![]() |
Organism: Synthetic construct
Method: SOLUTION NMR Release Date: 2024-02-07 Classification: DNA Ligands: 3WL |
![]() |
![]() |
Cryo-Em Structure Of Antibody 12-16 In Complex With Prefusion Sars-Cov-2 Spike Glycoprotein
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2023-10-04 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
![]() |
Cryo-Em Structure Of Antibody 12-19 In Complex With Prefusion Sars-Cov-2 Spike Glycoprotein
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2023-10-04 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
![]() |
Crystal Structure Of Neutralizing Antibody 80 In Complex With Sars-Cov-2 Receptor Binding Domain
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.12 Å Release Date: 2023-05-24 Classification: IMMUNE SYSTEM/VIRAL PROTEIN Ligands: NAG |
![]() |
Cryo-Em Structure Of Ntd-Directed Neutralizing Antibody Lp5 Fab In Complex With Sars-Cov-2 S2P Spike
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2022-05-25 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
![]() |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.64 Å Release Date: 2022-05-04 Classification: VIRAL PROTEIN/INHIBITOR Ligands: XTP, SCN |
![]() |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2022-05-04 Classification: VIRAL PROTEIN/INHIBITOR Ligands: V46, PO4, MG |
![]() |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.08 Å Release Date: 2022-05-04 Classification: VIRAL PROTEIN/INHIBITOR Ligands: W48, MG |
![]() |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.68 Å Release Date: 2022-05-04 Classification: VIRAL PROTEIN/INHIBITOR Ligands: I54, PO4 |




















